Works matching IS 02780232 AND DT 2022 AND VI 40 AND IP 2

Results: 20

Successful early use of anti‐SARS‐CoV‐2 monoclonal neutralizing antibodies in SARS‐CoV‐2 infected hematological patients – A Czech multicenter experience.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 280, doi. 10.1002/hon.2974

By:

Weinbergerová, Barbora;
Demel, Ivo;
Víšek, Benjamin;
Válka, Jan;
Čerňan, Martin;
Jindra, Pavel;
Novák, Jan;
Stejskal, Lukáš;
Kovácsová, Flóra;
Kabut, Tomáš;
Szotkowski, Tomáš;
Hájek, Roman;
Žák, Pavel;
Cetkovský, Petr;
Král, Zdeněk;
Mayer, Jiří

Publication type:

Article

Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 191, doi. 10.1002/hon.2969

By:

Belyaeva, Elizaveta;
Rubenstein, Ayelet;
Pierson, Sheila K.;
Dalldorf, Delaney;
Frank, Dale;
Lim, Megan S.;
Fajgenbaum, David C.

Publication type:

Article

Cardiotoxicity as an adverse effect of immunomodulatory drugs and proteasome inhibitors in multiple myeloma: A network meta‐analysis of randomized clinical trials.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 233, doi. 10.1002/hon.2959

By:

Das, Avash;
Dasgupta, Subhajit;
Gong, Yan;
Shah, Urvi A.;
Fradley, Michael G.;
Cheng, Richard K.;
Roy, Bhaskar;
Guha, Avirup

Publication type:

Article

Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 269, doi. 10.1002/hon.2964

By:

Brackman, Deanna;
Eckert, Doerthe;
Menon, Rajeev;
Salem, Ahmed Hamed;
Potluri, Jalaja;
Smith, B. Douglas;
Wei, Andrew H.;
Hayslip, John;
Miles, Dale;
Mensing, Sven;
Gopalakrishnan, Sathej;
Zha, Jiuhong

Publication type:

Article

Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T‐cell lymphoma: A FIL phase 2 study.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 307, doi. 10.1002/hon.2963

By:

Stefoni, Vittorio;
Pellegrini, Cinzia;
Argnani, Lisa;
Corradini, Paolo;
Dodero, Anna;
Orsucci, Lorella;
Volpetti, Stefano;
Zinzani, Pier Luigi

Publication type:

Article

Use of serum B‐cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 243, doi. 10.1002/hon.2961

By:

Bujarski, Sean;
Sutanto, Christine;
Spektor, Tanya M.;
To, Jennifer;
Swift, Regina A.;
Green, Tracy;
Eades, Benjamin R.;
Emamy‐Sadr, Marsiye;
Souther, Eric;
Berenson, James R.

Publication type:

Article

Efficacy and follow‐up of humanized anti‐BCMA CAR‐T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary‐extraosseous, extramedullary‐bone related, and without extramedullary disease.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 223, doi. 10.1002/hon.2958

By:

Li, Wei;
Liu, Meijing;
Yuan, Ting;
Yan, Lixiang;
Cui, Rui;
Deng, Qi

Publication type:

Article

Sinonasal B‐cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B‐cell lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 160, doi. 10.1002/hon.2968

By:

Eriksen, Patrick R. G.;
Clasen‐Linde, Erik;
Nully Brown, Peter de;
Haunstrup, Laura;
Christoffersen, Mette;
Asdahl, Peter;
Thomsen, Troels Møller;
Harwood, Cecilie Dupont;
Heegaard, Steffen;
Buchwald, Christian von

Publication type:

Article

CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 258, doi. 10.1002/hon.2951

By:

Liao, Xiong‐yu;
Fang, Jian‐pei;
Zhou, Dun‐hua;
Qiu, Kun‐yin

Publication type:

Article

Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B‐cell lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 172, doi. 10.1002/hon.2956

By:

Cao, Di;
Cao, Xia;
Jiang, Yu;
Xu, Juan;
Zheng, Yuhuan;
Kang, Deying;
Xu, Caigang

Publication type:

Article

Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 212, doi. 10.1002/hon.2955

By:

Shang, Yufeng;
Jin, Yanxia;
Liu, Hailing;
Ding, Lu;
Tong, Xiqin;
Tu, Honglei;
Zang, Longkai;
Lin, Chenyao;
Hu, Jinsong;
Zhou, Fuling

Publication type:

Article

First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 297, doi. 10.1002/hon.2953

By:

Mozas, Pablo;
Rivero, Andrea;
Rivas‐Delgado, Alfredo;
Correa, Juan Gonzalo;
Condom, Maria;
Nadeu, Ferran;
Giné, Eva;
Delgado, Julio;
Villamor, Neus;
Campo, Elías;
Magnano, Laura;
López‐Guillermo, Armando

Publication type:

Article

Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre‐CAR T‐cell era.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 292, doi. 10.1002/hon.2952

By:

Mathys, Anina;
Bacher, Ulrike;
Banz, Yara;
Legros, Myriam;
Mansouri Taleghani, Behrouz;
Novak, Urban;
Pabst, Thomas

Publication type:

Article

SARS‐CoV‐2 vaccine response in CAR T‐cell therapy recipients: A systematic review and preliminary observations.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 287, doi. 10.1002/hon.2957

By:

Abid, Muhammad Abbas;
Abid, Muhammad Bilal

Publication type:

Article

Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950

By:

Wang, Hanyin;
Tian, Shulan;
Zhao, Qing;
Blumenschein, Wendy;
Yearley, Jennifer H.;
Secreto, Charla R.;
Sinha, Sutapa;
Call, Timothy G.;
Wang, Yucai;
Parikh, Sameer A.;
Kenderian, Saad S.;
He, Rong;
Leis, Jose F.;
Shi, Min;
Van Dyke, Daniel L.;
Kay, Neil E.;
Slager, Susan L.;
Braggio, Esteban;
Yan, Huihuang;
Ding, Wei

Publication type:

Article

Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 249, doi. 10.1002/hon.2948

By:

Yuan, Tian;
Wang, Jinhuan;
Shi, Ce;
Wang, Yi;
Xia, Bing;
Xu, Wen;
Yang, Hongliang;
Yang, Yaling;
Ye, Matthew T.;
Khalid, Samah;
Liang, Yong;
Tian, Chen;
You, M. James;
Wang, Yafei

Publication type:

Article

Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 181, doi. 10.1002/hon.2947

By:

Tissino, Erika;
Pivetta, Eliana;
Capuano, Alessandra;
Capasso, Guido;
Bomben, Riccardo;
Caldana, Chiara;
Rossi, Francesca Maria;
Pozzo, Federico;
Benedetti, Dania;
Boldorini, Renzo;
Gaidano, Gianluca;
Rossi, Davide;
Zamò, Alberto;
Hartmann, Tanja Nicole;
Doliana, Roberto;
Colombatti, Alfonso;
Gattei, Valter;
Spessotto, Paola;
Zucchetto, Antonella

Publication type:

Article

Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 129, doi. 10.1002/hon.2943

By:

Eyre, Toby A.;
Hori, Satoshi;
Munir, Talha

Publication type:

Article

Salvage therapy with "Dara‐KDT‐P(A)CE" in heavily pretreated, high‐risk, proliferative, relapsed/refractory multiple myeloma.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 202, doi. 10.1002/hon.2949

By:

Zhou, Xiang;
Ruckdeschel, Anna;
Peter, Jessica;
Böckle, David;
Hornburger, Hannah;
Danhof, Sophia;
Steinhardt, Maximilian Johannes;
Heimeshoff, Larissa;
Einsele, Hermann;
Kortüm, Klaus Martin;
Rasche, Leo

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2022, v. 40, n. 2, p. 127, doi. 10.1002/hon.2890
Publication type:: Article